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Abstract
Coronavirus disease-2019 (COVID-19) is an infectious acute respiratory disease caused by SARS-CoV-2. The 
protein that plays a role in the entry of SARS-CoV-2 into human cells is the surface protein, or the Spike, which is 
thought to be the effective vaccine target to prevent SARS-CoV-2 infection. Until December 2020, Indonesia has 
reported 106 SARS-CoV-2 genome sequences identified from COVID-19 positive patients. The purpose of this 
study was to analyze the phylogenetic relationship of the Spike protein of the Indonesian isolates of SARS-CoV-2 
Indonesian, as well as the virus mutations and their effects on changes in the amino acid. The 106 Indonesian 
SARS-CoV-2 genomes were downloaded from GISAID and the Spike nucleotide and amino acid sequences were 
analyzed by multiple sequence alignment (MSA) and mutation analysis using the ClustalW method. Phylogenetic 
trees were created using the Neighbor-Joining method in MEGA-X software. The results showed that 30 of the 
106 Indonesian isolate SARS-CoV-2 Spike were 100% identical to the Wuhan-Hu-1, while the remaining 76 had 
experienced mutations at 1-4 sites. There were 43-point mutations in the Spike gene, 27 of which led to amino 
acid changes and four had not been reported in other countries. The global mutation D614G was found in 60 
Indonesian isolates , of which West Java was the province with the most reports. The phylogenetic of Spike showed 
that the Indonesian samples have been divided into several branches that are far from Wuhan-Hu-1. This study 
indicates the possibility of differences in the protein structure of Indonesian isolate SARS-CoV-2 Spike that need 
to be further studied to manufacture a vaccine against the Indonesian strain of SARS-CoV-2.
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Analisis Mutasi dan Filogenetik Glikoprotein Spike Severe-Acute-Respiratory-
Syndrome-Coronavirus-2 (SARS-CoV-2) Isolat Indonesia
Abstrak
Penyakit Coronavirus-2019 (COVID-19) adalah penyakit saluran pernapasan akut menular yang disebabkan 
oleh SARS-CoV-2. Protein yang berperan pada masuknya SARS-CoV-2 ke dalam sel manusia adalah protein 
permukaan Spike yang dianggap sebagai target vaksin yang efektif untuk mencegah infeksi SARS-CoV-2. Sampai 
Desember 2020, Indonesia telah melaporkan 106 urutan genom SARS-CoV-2 dari pasien positif COVID-19. Tujuan 
penelitian ini adalah menganalisis hubungan filogenetik dari Spike SARS-CoV-2 Indonesia, serta menganalisis 
mutasi dan pengaruhnya terhadap perubahan asam amino. Sebanyak 106 genom SARS-CoV-2 Indonesia diunduh 
dari GISAID, urutan nukleotida dan asam amino spike dianalisis dengan Multiple-Sequence-Alignment/MSA dan 
analisis mutasi menggunakan metode Clustal W. Pohon filogenetik dibuat menggunakan metode Neighbor-Joining 
dalam perangkat lunak MEGA-X. Hasil penelitian menunjukkan 30 dari 106 spike SARS-CoV-2 Indonesia 100% 
identik dengan Wuhan-Hu-1, sedangkan 76 sisanya mengalami mutasi di 1-4 lokasi. Ada 43 titik mutasi pada gen 
Spike, 27 di antaranya menyebabkan perubahan asam amino dan empat di antaranya belum dilaporkan di negara 
lain. Mutasi global D614G ditemukan pada 60 orang Indonesia, Jawa Barat merupakan provinsi dengan laporan 
terbanyak. Pohon filogenetik spike menunjukkan sampel Indonesia telah terbagi atas beberapa cabang yang jauh 
dari Wuhan-Hu-1. Simpulan, penelitian ini menunjukkan kemungkinan perbedaan struktur protein SARS-CoV-2 
Indonesia yang perlu dikaji lebih lanjut guna pembuatan vaksin melawan SARS-CoV-2 strain Indonesia.
Kata kunci: Analisis filogenetik, mutasi, SARS-CoV-2, spike
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Introduction
Coronavirus disease 2019 (COVID-19) pandemic 
caused by Severe Acute Respiratory Syndrome-
Coronavirus 2 (SARS-CoV-2) has recently become 
a global health threat. Coronaviruses are a large 
family of viruses that infect the upper respiratory 
tract in humans and other mammals. Three 
coronavirus pandemics have been reported in 
the 21st century, i.e., SARS in 2002, MERS in 2012, 
and COVID-19 in 2019. 
The current coronavirus pandemic is caused 
by a new type of coronavirus found in December 
2019 that causes an outbreak of the respiratory 
inflammatory disease in the city of Wuhan, which 
is the capital city of China’s Hubei province.1,2 
This coronavirus is then named Severe Acute 
Respiratory Syndrome-Coronavirus 2 (SARS-
CoV-2), owing to its RNA genome that is 79.5% 
identical to the SARS-CoV.1,3 Both viruses belong 
to the B clade of the genus Beta coronavirus. 
COVID-19 was initially associated with the 
Huanan seafood and animal market in Wuhan; 
however, this is still debatable. The fact that this 
coronavirus has gained the ability for human-to-
human transmission making it a highly infectious 
zoonotic virus that grows  exponentially, leading 
to the emergence of millions of cases globally 
and creating a worldwide pandemic.1 By 3 
April 2021, the number of COVID-19 cases has 
reached more than 130 millions worldwide with 
2.8 million deaths. In Indonesia, more than 1.5 
million people have been infected by this virus 
and 41,151 of them died because of this disease. 
The SARS-CoV-2 Wuhan-Hu-1 (NC_045512.2) 
virus is known to have 96.2% homology with 
SARS-CoV RaTG13 (MN996532), which is a virus 
that attacks the respiratory tract in bats. This has 
led to the assumption that SARS-CoV-2 is a virus 
that undergoes zoonosis from bats to humans 
after several mutations in the genome, causing 
this virus to infect and be transmitted between 
humans.1
The SARS-CoV-2 virus is a positive-strand 
RNA virus with a genome size of ~29,900 
nucleotides.2 The genomic RNA (gRNA) of 
coronavirus contains 5’cap and 3’poli A and can 
act as an mRNA that  can be directly translated 
into poly-proteins. At the 5 ‘end, there are two 
open reading frames (ORF) that encode very 
long replicase polyproteins, ORF1a and ORF1b, 
which  cover 20 kb or two-thirds of the genome. 
Each of these ORFs are translated into large 
polyproteins, namely 1a and 1ab, where the 
pp1ab is expressed through the translation shift 
coded by the 3’ORF1a end. Polyproteins are co-
translationally digested into 16 proteins, which 
generally have enzymatic activities including two 
proteases that modify RNAs, such as polymerase 
and helicase. After ORF1b, there is ORF2-ORF10 
which encodes structural proteins consisting of 
Spike (S), Membrane protein (M), an Envelope 
protein (E), and Nucleo-capsid protein (N). 
Several nonstructural genes that encode small 
accessory proteins that do not play a role in 
replication but positioned among structural 
genes that play a role in interactions with the 
host are also observed.4
The phylogenetic and bioinformatics analysis 
of SARS-CoV-2 against other virus species has 
been performed by several researchers. One of 
these researchers is Lu et al.2 who demonstrated 
that of the 5 representative coronavirus 
sub-genus, SARS-CoV-2 belongs to the Sarbe 
covirus subgenus. This subgenus can be further 
classified into 3 clades. Clade 1 consists of SARS-
related CoV that is found in Kenya and Bulgaria; 
clade 2 consists of 10 sequences of SARS-CoV-2 
from Wuhan and SARS that are derived from bats 
from Zhoushan, China; and clade 3 that consists 
of Bat SARS-like and several SARS strains that 
attack humans. SARS-CoV-2 has a very distant 
relationship with SARS-CoV. The results of this 
phylogenetic analysis prove that SARS-CoV-2 is a 
new type of Betacoronavirus under the B lineage 
of the subgenus Sarbecovirus.2
Jaimes et al.5 have conducted phylogenetic 
and bioinformatic analysis, as well as  structural 
modeling of the SARS-CoV-2 Spike protein based 
on its homology with SARS-CoV. Spike protein 
plays a very important role in viral infection as 
it mediates the attachment, fusion, and entry 
of the virus into the target cells. The Receptor 
Binding Domain (RBD) on the Spike protein 
plays a role in recognizing and interacting with 
the Angiotensin-Converting Enzyme 2 (ACE-
2) receptor on the target cell surface. This 
interaction occurs between several amino acids 
on RBD, which is referred to as the Receptor 
Binding Motif (RBM) with ACE-2 receptors. 
Furthermore, fusion occurs to the host 
membrane, involving the fusion of peptides (FP) 
and HR1 and 2 (HR =Heptad region). The process 
used by the virus to enter the host requires the 
role of a trans-membrane host protease, namely 
TMPRSS2 (Trans-membrane serine protease), 
which will bypass the ACE-2 receptor and 
activate Spike, enabling the SARS-CoV-2 to enter 
the host cell through endocytosis.6
Spike is a large glycoprotein with a size of 
about 180 kDa and consists of two domains: 
the S1 domain (receptor binding domain) and 
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the S2 domain (fusion domain). The N-terminal 
and C-terminal regions of the S protein form a 
distinctive crown-like trimer when observed 
under an electron microscope.7 The S1 domain 
contains the RBD (amino acids333-527), in 
which the RBM is the amino acids438-506, 
that interacts directly with the ACE-2 receptor. 
Furthermore, there are Fusion peptide (FP), 
Heptad Region (HR) 1 and 2, and Trans-
membrane TM area required for fusion to the 
membrane and for introducing the virus into the 
target cells.8
Spike, RBD, and RBM are the targets for 
vaccines against SARS-CoV-2. Several studies 
have reported the expression of whole Spike, 
S1 domain, or RBD in heterologous protein 
expression systems.9,10 Viral genomes, including 
that of the coronavirus, are reported to be 
rapidly evolving due to the accumulation of 
mutations caused by replication errors in the 
host cells. Although SARS-CoV-2 is known to have 
a proofreading mechanism, several different 
strains have been found, which indicate the 
occurrence of mutations.3
In this study, an analysis of the phylogenetic 
relationship of Spike protein from the Indonesian 
SARS-CoV-2 strain was carried out based on the 
comparison of the nucleotide and amino acids 
sequence with the Wuhan-Hu-1 strain and 
strains from other countries.  Analysis on the 
relationship between mutations and changes in 
the amino acid sequence of the Spike protein of 
the SARS-CoV-2 strain was performed. The results 
of this study are expected to provide information 
about phylogenetic relationships and mutations 
in the Spike protein of SARS-CoV-2 to be used as 
a reference for vaccine candidates in Indonesia.
Methods
This was a  bioinformatic study without any wet 
lab experiment involving human participants or 
animals. It employed an ASUS X200MA-KX636D 
laptop with a turbo boost speed specification 
of ~2.58 GHz and 2GB RAM. The gene encoded 
SARS-CoV-2 Spike glycoprotein (3822 bp) was 
obtained from the GenBank (National Center for 
Biotechnology Information, USA) and the Global 
Initiative on Sharing All Influenza Data (GISAID) 
EpiCoV database (Germany). The software 
used in this study was Lasergene version 7.1.0 
(DNASTAR, USA),  Snapgene Viewer 5.1.5 (USA), 
and MEGA-X (Molecular Evolutionary Genetic 
Analyzes). Data were collected from March to 
December 2020.
Indonesian and nine global SARS-CoV-2 
genome sequences were retrieved from the 
GISAID database. The sequences (supplemental 
information file) were annotated according 
to the sample ID on GISAID with additional 
serial numbers to facilitate analysis. All 
genome sequences were analyzed by Seqman 
on Lasergene to determine the position of 
the S gene by comparing it with the reference 
sequence (GenBank: NC_045512.2). Then, the 
S gene sequence from each sample was cut 
according to the length of the reference sequence, 
which removes any truncated sequences. The 
nucleotide sequences of the S genes were 
translated into amino acid sequences using the 
EditSeq on Lasergene based on standard genetic 
code. All nucleotide and amino acid sequence 
files were then converted into FASTA format.
The SARS-CoV-2 Spike gene reference 
sequence used was the Wuhan-Hu-1 available 
in the GenBank (NC_045512.2) with a length 
of 29,903 bases. For the Spike, the Spike 
glycoprotein reference sequence (GenBank: 
YP_009724390.1) with a length of 1273 amino 
acids was used as reference. In this study, 
106 sequences of the SARS-CoV-2 genome 
from Indonesia were included and 9 genome 
sequences from other countries were randomly 
selected and genome sequences from India, 
Italy, Malaysia, Kazakhstan, Saudi Arabia, 
China, Singapore, Taiwan, and the United States 
were used in the study (The ID of samples are 
presented in the supplement file).
Both nucleotide and amino acid sequences 
of Spike were analyzed using the MSA with 
the default Clustal W method in MEGA-X using 
Wuhan-Hu-1 as the reference. Gap opening and 
extension penalties were set to 10.0 and 0.20, 
respectively. The negative matrix was off and 
delay divergent cutoff was 30%. The resulting 
alignment  was stored in the FASTA format for 
further analysis using the Snap gene program to 
interpret the mutations and changes in amino 
acids in the Spike genes/protein.
MSA with the Clustal W method was used to 
analyze the nucleotide and amino acid sequences 
of Spike in FASTA format in this study.11 This 
program aligns the nucleotide/amino acid 
sequences so that mutations that occur in the 
Indonesian SARS-CoV-2 Spike protein sequence 
can be analyzed and compared to the Wuhan-
Hu-1 sequence. Clustal W uses a progressive 
alignment method where the most similar 
sequences are aligned first, followed by a more 
different sequence to obtain a global alignment. 
The algorithm begins by calculating the distance 
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Tabel Point Mutation in 76 Indonesian Samples
Table is constructed based on MSA of the nucleotide and amino acid sequences of the Spike protein. From 76 Indonesian 
samples that were not 100% identical to the Wuhan-1 sequence, 43 mutation points were found, with 27 mutations 
causing amino acid changes. The type of amino acid change varied between C (conservative), SC (semi-conservative), 
and NC (non-conservative). U=was also found in other countries’ samples; B=was only seen in the Indonesian sample.
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Phylogenetic tree of 76 Indonesia's Spike Genes Compared to Nine Overseas Samples, 
Wuhan-Hu-1, BatCoVRatG, and SARS-CoV
Figure 1
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The Phylogenetic Tree was constructed based on the Spike Gene's 3822 bases using the Neighbor-Joining 
Method in MEGA X Software
Figure 2 Phylogenetic Trees of 1273 Amino Acids of S Protein from 76 Indonesian Samples Compared 
   to the Wuhan-1 Sequence
The tree was created using MEGA-X software
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Figure 4 D614G Mutation Distribution of in Spike Protein from 106 Indonesian Samples
Figure 3 SARS-CoV-2 Spike Protein Structure
Protein Spike consists of S1 domain containing NTD=N terminal domain, RBD=Receptor Binding 
domain, SD=Sub Domain 1 and 2; domain S2 contains FP=fusion peptide, HR=Heptad Repeat 1 and 2; 
TM=transmembrane Region and IC=Intracellular domain.29
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matrix between each pair of sequences based on 
the value in pairwise sequence alignment, after 
which the neighbor-joining method algorithm 
with midpoint rooting is used to build a guide 
tree used to make the global alignment.11
The MSA result was then used to construct the 
phylogenetic tree to determine the relationship 
between the Indonesian samples, reference 
sequences, and samples from other countries. 
A Neighbor-Joining method in the MEGA-X was 
selected to construct the phylogenetic tree since 
the data was free from any truncated sequence, 
which would be vulnerable for such a method.12,13
Results
The MSA analysis of Indonesian sequences, 
when compared to the Wuhan-Hu-1 sequence, 
demonstrated that 30 of 106 Indonesian 
sequences were 100% identical to Wuhan-Hu-1. 
The comparison between the remaining 76 
mutated Indonesian sequences and Wuhan-Hu-1 
is  shown in Table 1. Based on the results, it was 
revealed that there were 43 points mutations in 
the Indonesian sequences, with each sequence 
mutated at 1–4 points. These indicate a high 
mutation rate with varying positions in the Spike 
gene.
Based on the MSA of the Spike amino acid 
sequence of 76 mutated samples,  27 non-
synonymous mutations were identified to cause 
amino acid changes. In addition, there were 16 
mutations that were synonymous mutations. 
From the perspective  of the amino acid changes, 
it was demonstrated that 6 were conservative 
mutations (size and hydropathy conserved), 
8 were semi-conservative mutations (size 
or hydropathy conserved) and 13 were non-
conservative mutations (size and hydropathy 
non-conserved). Non-conservative mutations 
are mutations that produce changes in amino 
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acids of different sizes and properties. These 
mutations are thought to result in changes in the 
three-dimensional structure of the protein. When 
compared to the data in the GISAID database, 
the following four mutations were identified as 
only occuring in the Indonesian samples: T22P, 
S116C, N185Y, and K811I. Other mutations 
identified in the remaining Indonesian samples 
were also seen in samples from other countries.
Thirty Indonesian samples were100% 
identical to the Wuhan-Hu-1. These sequences 
were not included in the phylogenic analysis, 
as this analysis was only performed on samples 
that was different from Wuhan-Hu-1 The S gene 
from 30 Indonesian samples that were identical 
to Wuhan-Hu-1 based on the MSA results are 
located in the same branch as Wuhan-Hu-1 and 
different from BatCoV-RatG13 with a distance 
of 3.6 x 100 nucleotide substitutions (data not 
shown). Most of the samples belonged to clade 
L and only two samples belonged to clade O 
(sample no. 63 and 81) and one belonged to GH 
clade (sample 91). Based on the information in 
the GISAID database, most of these samples were 
sent to GISAID in May-October 2020. 
The phylogenetic tree of 76 samples that are 
different from Wuhan-Hu-1 is shown in Figure 1. 
Based on this tree, the Indonesian samples were 
divided into several branches of small groups 
based on the mutation that occurred. This group 
may be large if the number of samples was 
added. Furthermore, it seems that the similarity 
of some samples to samples from abroad might 
link to the patient’s travel history; however, it is 
also possible that it happened by chance because 
this virus mutates rapidly. There are even some 
sample sequences that are presented earlier than 
the Wuhan-Hu-1 reference sequence. This may 
happen because the virus mutates repeatedly. 
The phylogenetic tree uses a specific algorithm 
to be able to count back mutation events. The 
phylogenetic tree also reflects the the fact that 
rapid mutation of changes do not occur with time; 
thus, the phylogenetic tree of the SARS-CoV-2 
virus cannot be used to describe the common 
ancestor of the mutations. The SARS-CoV-2 virus 
mutates less quickly than other viruses because 
this virus has a proofreading mechanism to 
correct errors3 but because the virus spreads 
very rapidly, there is not enough time to correct 
the reading errors, which leads to mutations. 
The phylogenetic tree based on the amino 
acid sequence of the Spike protein is shown in 
Figure 2. It can be seen that the relationship of 
S gene is slightly different from the amino acid 
sequence. This is because not all mutations cause 
amino acid to change and in some mutations, 
even when there is a change in the amino acid, 
the properties are still the same. Phylogenetic 
analysis based on the amino acid sequence of 
the Indonesian Spike protein shows that the 
Indonesian Spike strain is divided into several 
major branches based on the mutations that 
change amino acids.
Discussion
The SARS-CoV-2 Spike protein monomer 
consists of NTD, N-terminal domain; RBD, 
Receptor binding domain; SD1, subdomain 1; 
SD2, subdomain 2; FP, fusion peptide; HR1, 
heptad repeat 1; HR2, heptad repeat 2; TM, 
transmembrane region; IC, intracellular domain 
(Figure 3). The position of RBD is at the 319-541 
residues. This RBD contains the  RBM (Receptor 
Binding Motive), which is the key to binding 
Spike with ACE-2, with N439, L455, F486, Q493, 
Q498, and N501 as the amino acids that play a 
role in the binding.14
Similar studies have been reported from 
different areas.15 One of these study uses full-
length genome sequences to yield a phylogenetic 
analysis of SARS-CoV-2 circulating in Yogyakarta 
and Central Java, Indonesia. This is different from 
this present study as this study focuses on the 
phylogeny of amino acid sequences translated 
from, spike protein genome of SARS-CoV-2 from 
various regions in Indonesia, not only from 
Yogyakarta and Central Java 
The results of this study demonstrated that 15 
mutations that cause amino acid changes occur 
in the NTD domain, but each of these mutations 
only occurs in 1-2 samples, with two mutations 
in RBD causes amino acid changes (A352S and 
S477I). The A352S mutation is a conservative 
mutation that changes the hydrophobic amino 
acid, Alanine, to a polar Serine while the S477I 
mutation is non-conservative where the amino 
acid Serine (polar) changes to Isoleucine 
(hydrophobic). Yuan et al.16 reported that the 
A352S mutation is located in the opposite 
position to the binding site of RBD in ACE-2 
receptor and in the same position as the epitope 
binding of the CR3022 antibody (neutralizing 
antibody) isolated from convalescent SARS-
CoV patients. However, the A352S mutation in 
SARS-CoV-2 has not been previously reported, 
so its effect on binding to ACE-2 receptors and 
antibodies is not known. Meanwhile, the S477I 
mutation has been reported to strengthen the 
bond between Spike and the ACE receptor.17
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Twelve other mutations have been identified 
to cause amino acid changes in post-RBD 
domains. These mutations have also generally 
been reported in other countries. The analysis 
in this study indicates that the D614G mutation 
occurs in 60 Indonesian samples (Table 1). This 
mutation is semi-conservative in that there 
is a change in the amino acid Aspartic acid 
(negatively charged) to glycine (neutral).
Several studies have reported that the D614G 
mutation in the SARS-CoV-2 Spike protein is a 
global mutation that occurs in many countries.18 
This mutation first appears in Europe, then 
spreads to the USA, Canada, and Australia, and 
worldwide. The MSA results of the SARS-CoV-2 
Spike protein in some samples from different 
countries, when compared against the Spike 
reference sequence (YP_009724390.1), present 
a D614G mutation of the SARS-CoV-2 Spike 
protein in patients: USA 426025, Singapore 
443249, Saudi Arabia 437758, Kazakhstan 
454586, and Italy 417418. Based on the analysis 
of the SARS-CoV-2 genome in Europe from late 
December 2019 to mid-March 2020, the D614G 
mutation in S protein is the most dominant 
mutation in Europe, estimated to appear in mid 
to late January 2020.19
The D614G mutation is reported to change the 
conformation of S protein to be more dynamic, 
which affects the ability of Spike to be infected, 
facilitates fusion, and increases viral titer in 
the host. D614 is located on the surface of the 
Spike protomer that interacts with neighboring 
protomers. Hydrogen bonds are formed between 
the D614 side chains of protomer-1 and T859 
of protomer-2. The change in G614 removes 
this hydrogen bond, thereby increasing the 
flexibility and changing the interactions between 
protomers. This substitution can also modulate 
the glycosylation of N616, leading to an increase 
in the dynamics of the fusion peptide and 
probably also causing other effects. High viral 
titer is reported due to G614, causing virus entry 
no longer requires TMPRSS2 activities.18
D614G mutation is also known to be the 
cause of individuals to be susceptible to infection 
for the second time.18 One of the reasons for the 
increase in the global spread of the SARS-CoV-2 
virus is the mutation at position D614G.21 The 
increase in the spread of the SARS-CoV-2 virus 
due to the D614G mutation is also supported by 
other studies.22,23
The D614G mutation is thought to reduce 
the interaction between S1 and S2 units and 
facilitate the release of S1 from S2 bound to the 
viral membrane. The alternative structure-based 
hypothesis suggested that this mutation could 
affect the binding of RBD-ACE-2, although not 
directly because this site is not proximal to the 
binding interface. The RBD needs to be in an 
“up” position to engage with the ACE-2 receptor, 
and this site may allosterically alter the “up” and 
“down” transitions of RBD.15 The slightest change 
allows a conformational change of the dynamic S 
protein trimer. Therefore, experimental studies 
and more detailed modeling are needed to 
explain the effects of these mutations on the RBD 
transition.
Figure 4 depicts the distribution of D614G 
mutations in Indonesian patients. It can be 
seen from the 106 genome samples sent to 
GISAID that although DKI Jakarta province is 
the province that sends the highest number of 
of the SARS-CoV-2 genome sequences compared 
to other provinces in Indonesia, most cases 
of mutations are actually found in West Java 
Province, where 14 of the 18 samples sent show 
have undergone mutations. The D614G mutation 
is reported to make the virus more abundant in 
the upper respiratory tract, i.e., nose and mouth, 
making it easier for the virus to spread. However, 
the clinical symptoms of the D614G mutant are 
weaker than the wild type SARS-CoV-2 virus.24 A 
study by Ansori et al.25 in May 2020 that analyzed 
nine Indonesian samples in the GISAID database 
only found one D614G mutation in samples from 
Surabaya with ID: 437188. In November 2020, 
however, 60 D614G mutants are detected in 
106 Indonesian samples, showing how fast this 
SARS-CoV-2 mutants are spreading.
The phylogenetic analysis of S protein using 
the neighbor-joining method showed a variation 
in the distribution of the SARS-CoV-2 virus 
clade in Indonesia, and also a rapid mutation. 
Furthermore, it is also known that Indonesia’s 
SARS-CoV-2 may not have originated directly 
from China, but originated from different 
countries as reflected in the travel history of 
patients to various countries. There is also a 
possibility of local transmission that leads to 
mutations of the virus. 
The results of phylogenetic analysis that 
is based on the S protein of SARS-CoV-2 
Indonesian in this study are similar to the results 
of phylogenetic analysis on Indonesian SARS-
CoV-2 genome by the Next strain team based 
on data from GISAID from March to April 2020, 
showing the distribution of Indonesian clades 
that are categorized into clade B (L), B (O), and 
B. 1.36 (GH). This shows a close relationship 
with several countries such as the United States, 
Bangladesh, Nigeria, China, Taiwan, and Sweden.
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The findings of mutations that occur in the 
Spike gene of Indonesia’s SARS-CoV-2 and the 
results of the phylogenetic analysis of Indonesia’s 
S protein SARS-CoV-2 prove that Indonesia’s 
coronavirus strains are not 100% similar to 
viruses from other countries. There are several 
mutations in the S gene that need to be studied 
further to see their effect on the ability of SARS-
CoV-2 virus to infect and its interactions with 
antibodies considering that S protein is the main 
target of the subunit vaccine being developed in 
Indonesia.
In conclusion, this study shows the presence 
of highly mutated S gene in Indonesian SARS-
CoV-2 samples. Although the mutations identified 
are not located on the binding site of RBD or the 
antibody binding site, the effect of these mutations 
on changes in the structure and function of Spike 
needs to be studied in more in-deph manner, 
especially for the four specific mutations that 
only onccur in Indonesian samples. The D614G 
mutation, which is a global mutation, is seen in 
56% of the samples, indicating a higher spread 
of this mutant virus. The phylogenetic analysis 
of the nucleotide and amino acid sequences 
of Indonesian Spike samples shows that the 
Indonesian patients’ Spike has been divided into 
several small branches based on the mutation. 
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